Today's earnings webcast and conference call. At this time, all participants are in listen-only mode. We will open the line for questions following the prepared remarks. If you would like to ask a question, you can press the raise your hand button on the bottom right corner of the video player. I will now turn over the call to today's host. Please go ahead. Well, thank you, Maurice. Thank you, Lynn. Well, thank you all for being here. I am here together. My name is Floris Jan Cuypers. I am the CEO of NX Filtration, and I am here together with my two fellow board members, Michiel Staatsen and Jan Feie Zwiers. We will take you through the first half year results of 2026, and we will go through it slide by slide, and at the end, we will do some Q&A. Before I go into the slides that you see on the screen, I want to emphasize that we have a pretty good first half year of 2026 for NX Filtration. As you know, we have a clear execution path to growth and break even, and we try to optimize our speed. We do that through creating maximum focus on our key customers and OEMs, and with clear propositions, and with disciplined management in sales and across the company. We see our revenue has grown in the first half year by 19%. If you look at it from a last 12-month basis, it is +31%, and n otably, we have a record order intake of 61% higher than the same period last year, and a record order book, which is five times larger than at this moment last year. We see also that our margin remains very strong at 59%, reflecting our disciplined commercial focus and leading technology position. If you look at our commercial approach, as I said, it is about focus and discipline. We see tipping points in each region, across each region, which is different in each region. But it is happening in each region at the right time and for the right value proposition OEM combination. We see that reuse is very strong, but also drinking water. One notable milestone is in Europe, in Östersund, where we won a large and highly competitive tender where we are chosen as the partner of choice for drinking water in Sweden at large scale, and we are very proud of that. It is the largest order in our history. But notably also, and later on, Michiel will talk about it, we saw Heineken ordering for their breweries. We saw in Middle East good orders from Esli, for instance, in Turkey growing fast. And Gradiant, a well-known water company, is also ordering from our robust membranes. The OEM funnel, we see strong progress, both from the number of OEMs that we are in contact with is 193, but also the healthy development in that funnel from early technology vetting into first orders and repeat orders. We progress on our path towards EBITDA breakeven. We are very disciplined in how we manage our assets and cost base and bringing that also in line with our revenue curve. Our cash position at the end, 30 June this year, is EUR 18.4 million. The large CapEx is behind us as we have now fully invested in our new factory, and we are well-positioned to further execute on our strategy with maximum speed. If you then go to the next slide, you see the revenue step-up, which is on the left side, showing 19% year-on-year growth in the first half year. If you compare it last 12 months, ending 30 June, and comparing that with the last 12 months ending 30 June 2025, you see 31% growth. On the right side, you see the record order intake, record order book. That is very positive. Underlying, although the 19% growth in the first half year is something that we need to try to compensate with even more growth in H2, underlying, we see very, very positive metrics. As you know, we have a competitive offering, not only in our flagship nanofiltration products, which is over 90 times installation sold and over 40 or 50 in commissioning, s o very positive. We win against competitors and the market. Our OEMs, our engineering consultants, and utilities and industries know that it works. It is effective, it is simple, and it is proven. Also, we are competitive in ultrafiltration, where we have one-on-one replacements with our key competitors, the names that you know, Pentair, Veolia, et cetera. So, we have a broad portfolio. We launched 65 sq m, 80 sq m, and we see fast adoption in our distributor and OEM base. In microfiltration, our food and beverage sector, we saw also diversification with new orders from Heineken and of course, customers, other major brewers that are also ordering with us. If you now zoom out, you see diversification in geography. So, in all geographies, we see very positive momentum also with multiple OEMs and with all these VMCs. So, drinking water, but also reuse for data centers, for food, for irrigation, and also contaminants removal. I just want to give a bit more color. For instance, last week, I was in the Middle East with our team. All of our teams have regional offsites with customers involved. I visited one or two of those. I was in Istanbul, in Turkey. They have huge momentum. I see that the clarity in which our customers understand our value proposition in nanofiltration, but also see our broad ultrafiltration and microfiltration offering, see us as a really membrane technology platform. So, we are a very viable, mature, broad membrane technology platform, which is future-proof, no [inaudible] in there. And also, they see our service offering. We have customer intimacy. We are close to customers, and that gives a lot of comfort. One thing to light out, for instance, in Pakistan, in 70 villages, we make drinking water with NX Filtration ultrafiltration. So, that is also, from a purpose and ESG point of view, amazingly positive and motivational. If you go to the next slide, slide four, shortly, you see the breakdown in terms of our revenue base. Again, Asia is growing very strong, not only in India, but also in Southeast Asia, in Japan, and elsewhere. So, that's more than half of our revenue. We see Europe with a decent chunk, 27%, not only in Sweden but also in Belgium, in France, in Spain, in Italy, in the U.K. and across the continent. In North America, that includes Mexico, it's 5%, but we see very positive early signs also in the U.S. of, for us, a good recovery, and then, the rest of the world is also. I think we continue to look at sales performance from our salespeople to give them the right focus, but also in terms of sales performance, getting new people on board if that is needed. Sometimes, also, that means changing people that are currently in the company. I will hand it over to Michiel. Thank you, Floris Jan. Not only did we build a strong commercial team, we also sharpened our in and external communication along four clear PNCs. PNCs with the highest impact, where we show clear advantages and differentiate in terms of better economics, lower chemical consumption, and lower energy consumption. This results in clear messaging to our customers and focuses our team on those opportunities with the highest chances of success. Now, I'll quickly run you through these PNCs. Number one, drinking water from surface water. We see clear growth potential since most surface waters are becoming more challenging to treat and drinking water standards are getting higher at the same time. The second, wastewater reuse for high-quality water. With growing demand for high-quality water globally, being it cooling water for energy production or data centers, food and beverage production or drinking water, we believe that wastewater reuse is one of the most important trends in the water market and will be an important growth driver for NX Filtration. Number three is about removing pollutants from industrial wastewaters. While these industrial wastewaters are becoming more and more complex, discharge limits are becoming stricter, and this requires robust, effective, and efficient technologies and solutions. We see our membranes increasingly becoming part of those solutions. Number four is all about clarifying beverages. While being a smaller market compared to the water treatment markets, we see that our PFAS-free membrane chemistry offers a very interesting and often better alternative for existing products in the market. After our commercial successes in beer and wine filtration, we are now exploring other applications such as pharma and protein recovery. I am very proud to announce that we have reached over 90 hollow fiber nanofiltration membrane projects worldwide. Nine, zero, 90. Please allow me to give some examples of where we are successfully implementing our unique technology. The world is facing different water challenges driven by climate change, demographics, and economic developments, resulting in different needs when it comes to water treatment. Let me start with the Americas. There, our success started with treating highly colored surface water in Canada. Then, we progressed to industrial waters in the U.S. And now in Mexico, we are commissioning the SAPAL projects, the largest hollow fiber nanofiltration-based indirect potable water reuse plants in the world. Looking forward, we expect increasing investments in the U.S. driven by PFAS regulations. In Latin America, we want to capitalize on our successes in wastewater reuse. Moving to India and the Middle East, we see increasing traction driven by investments in high-quality water recycling for cooling water, for data centers, and energy production, but also in other industrial applications. Here, we see water as a service upcoming as an important trend, and that will accelerate investments in water treatment facilities. As you already know, in Asia-Pacific, we are already applying our nanofiltration membranes for many, many years, treating highly colored water. In China and Asia, we see also many growth opportunities for wastewater reuse, driven by investments for industrial use, such as data centers and microelectronic production. When we look at Europe, our recent win in Sweden is a clear example of how our commercial approach leads to concrete results. The city of Östersund has awarded the largest nanofiltration-based drinking water plant in the world, and this is a very important milestone. It demonstrates the shift towards next-generation drinking water treatment in Sweden with resilient solutions, lowering the need for water treatment chemicals with less energy while meeting stricter drinking water regulations. It provides additional proof that our technology is getting widely accepted for drinking water applications. Also, it proves our growth strategy with our OEM partners, where we work together with strong regional system integrators who can deliver large projects. Together with our strong entrepreneurial partners, we are proud to be part of the state-of-the-art solution in Sweden that will provide safe and affordable drinking water to the people of Östersund. Now, I will zoom in on our OEM partners with whom we are progressing towards sustainable and recurring business. You might remember this visualization from our CMD, in which we project a typical trajectory we follow together with our partners. We start on the left side in the technology selection phase, to get our technology qualified for real-world application in the second phase, the first project realization, up to the installed base phase, where we are striving together for repeat orders and recurring replacement business. As you can see in the graph, we have increased the total number of OEM partners we are working with to 193. We were able to convert six additional OEMs to the installed base phase. For instance, respected OEMs as Applied Membranes in North America and Gradiant in Malaysia, while also increasing the number of OEMs in the first project realization phase. This means that we were able to broaden our base to drive the all-important future repeat business from. Despite the fact that this tunnel reflects on our nanofiltration offerings only, I also want to mention that we are gaining traction with our competitive ultrafiltration and microfiltration membranes, w ith an important first sale of our brand-new 80 sq m ultrafiltration membrane product to a greenfield project to the Turkish OEM, Esli, and o ur first full-scale beer filtration project with Heineken. As you well remember, in these ultrafiltration and microfiltration markets, we benefit from shorter sale cycles with replacements in existing membrane systems, and w e will remain our focus on broadening this customer base, further strengthening our business with repeat customers while driving for more and larger projects. As we all know, we need to do more to secure our water supplies and treat our polluted waters globally. With our technology, we enable robust and chemical-free solutions at a lower CO2 footprint compared with conventional solutions. With our UF and nano filtration water treatment membrane modules sold in the first half of 2026, we enabled the production of 371 billion liters of clean water while filtering out viruses, bacteria, plastics, pesticides, hormones, medicine residues, and even PFAS from polluted water sources such as rivers, lakes, and wastewater streams. And with the implementation of our membranes compared with traditional technologies, we are helping our customers save over 4,000 tons of CO2 by avoiding the use of 7.8 million kilograms of water treatment chemicals. These are impact numbers that we are very proud of, and the numbers are very motivating for the whole team who are working on driving these numbers up with great dedication. Thank you, Michiel. In the next two slides, I will take you through the financials of H1 2026. I will start with a summary of the profit and loss. In H1 2026, total revenue reached EUR 7.8 million, representing 19% growth compared with H1 2025. We achieved a record order intake up by 61% year-on-year and an order book five times larger than one year ago, g ross margin of 59%, remaining strong and reflecting our leading technology position and disciplined commercial focus. We maintained operating expenses at last year's level while simultaneously growing the business, leading to a lower normalized EBITDA from loss from EUR 7.2 million in H1 2025 to EUR 6.7 million in H1 2026. Total FTEs slightly increased to 156 at the end of June 2026 versus 154 at the end of June 2025. We benefit from efficiencies resulting from our larger scale operations and continue to proactively align our cost levels to the timing of realization of our growth. Therewith, controlling our path towards break even. Now, to the balance sheet. We are fully invested in our new factory with H1 2026 CapEx totaling EUR 1.2 million, which is 71% lower than H1 2025. Working capital amounted to EUR 18.2 million, versus EUR 17.1 million at the end of June 2025. The increase is mainly due to higher receivables, partially offset by lower inventory levels and increased payables. Our cash position at the end of H1 2026 amounted to EUR 18.4 million, compared to a cash position of EUR 38.3 million at the end of H1 2025. Being fully invested in our new factory, we are well-positioned to execute our strategy and fund our growth ambitions. The last slide will be presented by Floris Jan. Thank you, Jan Feie. To reiterate and summarize our key priorities and outlook, we have four things that we mention here. We are continuing to build on the underlying commercial momentum, which is clearly visible. The building blocks for our company are in place. We have the strong foundation to support the growth in a broad and competitive portfolio of products, both in nano, ultra, and microfiltration. Our production capacity is there, ready to scale, CapEx behind us, and we have a strong global commercial organization with the eagerness and hunting spirit to drive further order book growth and revenue growth. In that commercial focus, we have, as you know since last year, our Capital Markets Day, a clear OEM funnel that we disciplined manage. We enhance the funnel, and we make it faster to go through stages. We have clearly defined strategic objectives and commercial milestones and act accordingly. Also, the flip side is that we have a disciplined path towards EBITDA break even, which we can view on in the coming time. Also, we have a disciplined management of our asset and cost base. We are well-positioned to execute our strategy and fund our planned growth, and we also have a clear multi-year on average 50% guidance on our revenue, and we are aligning our cost levels and our commercial rollout according to that. Now, back to the moderator, Lynn, for Q&A. Ladies and gentlemen, we will now begin the question- and- answer session. If you would like to ask a question, please press the raise your hand button on the bottom right corner of your video player, and please remember to unmute yourself. Our first question comes from Usama Tariq from ABN AMRO. Please go ahead. Yes. I hope I'm audible. Thank you for the opportunity, team, and congratulations on the good set of results. I have a few set of questions, if I may. Firstly, on the sales efforts for this year, I do see that you have put considerable efforts on the sales side. Would you update us on that front, on different geographies? My second question would be, on replacement cycle. While I do understand that maybe it would be early, but do you see some extent of a replacement cycle kicking in from, let's say, the older installed base that you still have? Those would be my first two questions. Thank you. Yeah. Thank you, Usama. Floris Jan here. The positive thing is, what we see in our commercial execution is that we see growth across the various regions, across the various VMCs and product groups, and also across multiple OEMs and distributors. I always summarize that we have more eggs in more baskets. So, in more OEMs and distributors, we are talking to more, we're selling to more, and per distributor and OEM, we see more projects, and t hat is very positive. It doesn't hinge on one or two or 10 big orders. No, we have a broad scope. Of course, having said that, we know that the macroeconomic environment around us is volatile. So, it's not a walk in the park everywhere in terms of timing of investments and those types of things. For instance, in the Middle East, there's a war there. You can argue that it has a bit of a slowdown in the path. We see it picking up again. But there, of course, you face that problem. Also, across other geographies, some people are hesitant to do large investments. I think we are countering that, and showing our underlying order book growth, and also our revenue growth because of the very big trends in water reuse and having real efficient treatment for clean drinking water. So, I think that's why we see a large drinking water order, but also multiple reuse activities in Europe. The data center boom is obvious. You read about it every day in the newspaper. We see people protesting against the water usage in data center areas. That plays to our technology clearly. Our nanofiltration is perfectly suited to help there with efficient reuse, the same for UF, and we have multiple conversations with AAA OEMs for data center and AI-related greater water reuse, but also for agriculture and drought. So, to answer your question about regions, we see in all region's growth, but particularly in Asia around AI and data centers, there's very positive tailwinds, and also in Europe, in terms of not only in Sweden but also in France, Belgium, Spain, t hey understand that our product works very well, s o, there's also good tailwinds. So, that is question one. Then question two is about replacement cycles. Now, I do think that, of course, for all of our products, we have replacement cycles. UF, we're doing that, and we're replacing competitive products. Also, for MF, we're replacing competitive product because they see our AAA quality and competitive pricing better than competitors. That is very positive. I guess you mean about nanofiltration, and that main point is, roughly, let us say, a replacement cycle for nanofiltration, depending on the water input, is around five years. So, yes, the first replacements are kicking in indeed, because already six years ago or seven years ago, we were making water in some countries. Yes, the replacement cycle is also for nanofiltration step by step kicking in. Very grateful. If I can just squeeze in one extra question, and then, I will go back into the queue, would be the outlook for H2 and next year. The order book is five times higher than H1 2025. Could you maybe provide some color? How much is it for 2026 or 2027? That would be really great. Thank you. Good question. Thank you so much. We have a multi-year guidance of an on average of 50% growth. That can mean a year 60%, it can mean a year 30%. We all know the text and what that means. We are eager to drive growth every year. We are also cognizant of the fact that H2 for this year needs to be a higher growth than the 90% that we saw in H1. The positive underlying signs are there. The order book, the order intake, 61% higher than last year, b ut we fight every day to make this a reality. Every day, all of our salespeople from around the world are fighting in July, August, September, October, November, December to bring our growth in that healthy space of that multi-year guidance, which I reiterated. I do think that, as you can see that the order book is there, the size of the order book now, it is about pulling things as much as we can into 2027 and even into Q4 2026. I think the better position that we are in now, we have a larger order book, we have a higher order intake, makes that a little bit easier than, for instance, last year this time, where we have the same dynamic of trying to pull orders of Q1 into Q4. Whereas it is not easy, we fight for it every day, and we are confident that we can make it happen. It requires, of course, also some of those discussions with our OEMs and customers to materialize fast, also in terms of revenue delivery, so shipping out of our warehouse. I hope it answers your question. Yes, it does. Thank you. I will go back into the queue. Thank you. Our next question is from Chase Coughlan from Lanschot Kempen. Please go ahead. Hi. Hope you can hear me all. Good morning. Good morning. Just a few questions from my side, and I will take them one by one, if that is all right. Starting with the North American segment, so there was, I think, a bit of a slowdown in terms of sales there. I am curious, is that sort of tariff-related? Is that based on just lumpy projects, or is there something else that I am missing? Yeah, thank you, Chase. It is more about the lumpiness of the projects. The big project in Mexico we talked about, that was last year. So, that is the lumpiness. Generally speaking, the traction and the dynamics in the North American market we see is very positive with multiple kinds of selectries for drink water projects going on or working towards bigger projects. Generally speaking, we are very positive in the North American market. The lumpiness was indeed [audio distortion]. Yeah. Maybe to add on, Michiel's point is very good, so w e see our team that has been reinvigorated. Two new salespeople. We are also recruiting again for technical salesperson, is that we see also there are multiple discussions for really good medium-sized demo projects that are tied to full scales. If we look at the board further two years ago, we see more healthy interactions with the OEMs, the first orders coming in, some of them have been reported, and hopefully, in the coming months, we can also report new orders there. But it is looking underlying, instantly positive. Okay, perfect. Yeah, that is exactly what I was trying to get a grasp around. Okay, I am just wondering also on the order book and the order intake. I recognize that you do not, at least I could not find it as sort of providing a hard or absolute number for order book or order intake, i s that something that you would be willing to share or willing to potentially report at some point just to get a better grasp on sort of how many years potentially that covers the sort of the visibility you have within that large order book? Yeah, we make very, as you can understand, very cognizant choices on what we report on every half year. I think these type of qualitative or semi-quantitative statements on the order book and order intake is something that we could consider to bring out during those moments. No guarantee, by the way, but I do think it's interesting that we already say something qualitatively or slightly quantitatively about the order intake and the order book as any industrial technology company normally does next to revenue numbers. But we're cognizant also of the fact that we try to do that every half year, but no guarantees. Yeah. Okay. No, it's very helpful having it on the [crosstalk]. Thank you. Appreciate it. We appreciate that. Great. Final question from me, and then, I'll jump back in queue. Could you talk a little bit about the growth between the different technologies, so the nanofiltration, microfiltration, and ultrafiltration? Did they all contribute to the growth in the first half? I presume that perhaps the gross margin came down a little bit year-over-year on mix effects, but can you provide a bit of a commentary around, I guess, the growth rate within those three different technologies? In terms of the importance of the product portfolio, at this stage, let's say all our three product lines are important, let's say, for the growth in the upcoming years. In the medium term, what we explained as well in previous calls, and of course, ultimately. Great. The growth engine. Sorry. Sorry, I think I cut out. Please go ahead. As I said, all three product lines are currently important for us, and you see across all those three product lines that we are growing and that we are healthy margins. For the longer term, let's say the growth engine for NX Filtration is the nanofiltration. But currently, let's say, if you look at the portfolio, then they are equally important for us at this stage. And we see healthy growth across all three product groups in this. Okay. Perfect. Okay. Thank you, gentlemen. I'll jump back in queue. The next question is from Kristof Samoy from KBC Securities. Please go ahead. Good morning. Thank you for taking my questions. I have two. I see that you capitalized some development costs in the first year. Could you explain what these developments would be into as to what types of products they relate? And then, secondly, on the order book again, my colleagues have been asking about it as well, but maybe, I will try from a different angle. I understand that the large Swedish order will only be for delivery in 2027. Could you maybe disclose how your order book would look like relative to last year's funds, excluding the large Swedish order? Thank you. And maybe the first question with regards to the development cost, we are continuously working, let's say improving, let's say, our product portfolio. Even in the second half of this year, we will have some new product introduction as well. As part of that, those products will bring certainly future economic benefits. Accounting-wise, we are allowed to capitalize those costs related to those developments. That is what you have seen in the figures of H1. Those costs are being capitalized. It is related to improving our products, introducing new products. Those costs are related to that. That is question one, and then question two, about the order book. Good question. Let me give the answer. First is for Östersund. I travel there in a couple of weeks' time to talk to the CEO of Purac and see Östersund and the civil works progression, and that indeed also influences the time at which we can take revenue in 2027 or even 2028. It is not, in that sense, that straightforward, okay, we sell it, and here you get it, and the delivery is then, because, that has with the permits, with the working capital in the project, with also the civil works fee. So, Östersund is 2027 and maybe partly 2028. That is one thing. Then, the other side is, it is not that we come from a super, super large, small order book. What I do know from my experience running industrial technology companies is that we are very happy that we, in the scale-up phase as a manufacturing company, coming from EUR 14.1 million revenue last year, growing fast towards our EBITDA breakeven, that I am very positive to see these healthy metrics in order intake and in order book. That makes it more predictable, more plannable also in our operations and for our working capital and our delivery liability. So, I am very positively positive about what we see. Of course, we try to further grow the order book into 2027, 2028 orders, even 2029 orders. Some of the discussions that we have, particularly with Asian OEMs in specifying nanofiltration in their end products, I cannot name a little bit more about that, is something for sales in 2029 that we are working on now. Yes, the order book is growing, and yes, that is positive. But our business is a combination of fast replacement cycles of sell now, deliver in next month, and sell now and deliver in three years. I hope that answers your question a little bit. Okay. Thank you. No further questions from me now. The next question is from Fernand de Boer from Degroof Petercam. Please go ahead. Fernand, you might need to unmute yourself. Yeah, should be un mute now. Sorry. Fernand de Boer from Degroof Petercam. A couple of questions my side is, one, coming back on, let's say, your remark that in the second half, you need to do better in terms than the 19% growth you had in the first half, but without providing any, let's say, color on how much that is. But I see consensus figures around EUR 19 million of sales. To ask the question a little bit differently, do you feel comfortable with that level of EUR 19 million in sales? That's the first question. And also, could you give a little bit more indication, if that sales come in, what that means for your cash burn in the second half? Yeah. Thank you, Fernand. I will do the first part, Floris Jan, and then, Jan Feie will do the second part. I think I want to reiterate that we have a multi-year on average 50% growth guidance. That can mean 60% in a year or 30% or 40% also for this year. That can happen. Both scenarios can happen. We are fighting, obviously, for a positive side of that bandwidth, and we do that every day. I do mind to say that we see strong order intake, and we see activity level high, number of customer meetings, number of quotes, closing skills of our salespeople. We monitor this every day and every week also personally as board. That looks positive. But the other side of the equation is delivery happens. Revenue happens when you deliver, so when it leaves our factory. If you, for instance, have orders only on one SKU, then, i t is very difficult because then you need to make that one SKU and get it out before 31st December. You want to also have a healthy spread of deliveries across MF, UF, and all those SKUs and also, nanofiltration. Yes, we are confident and fighting very hard to deliver on a good H2, with this very good growth rate in this year. But it is also hinging, of course, on our full capability to deliver everything before 31st of December and also convince some of our customer deliveries moving from Q1 next year into Q4 this year. I do not know if that is fully satisfying, but that is what we can say. The second part of your question was around. The second part of the question is what will happen then with the cash burn. Yeah. When we deliver more in the second half, then as a result, let us say for the second half, our EBITDA will improve. We have still, let us say, if you take our working capital levels, there is room for optimization. If you take where we currently are with the EUR 18 million, so the cash burn in the second half will then be as a result, will be lower. Yeah. I think the great thing about that, at least we feel good about it, is that we also have a very disciplined way of managing our asset base, so CapEx and OpEx cost base. Every week, we go through all cost line items, all CapEx items to really scrutinize. We do not cut in healthy meat, as you can understand, but we are also cognizant of the cash position, and that is why we are proud that with the same OpEx base, we have a higher revenue, and we continue to invest in efficiency and productivity, both on the CapEx side as well as on the OpEx side. Okay, thanks. Maybe, one last question. You mentioned Heineken a couple of times. Could you say which brewery that was, and also, that you then did the new brewery for them in Mexico and Brazil? Sorry, did not fully. Yeah, maybe you can answer the question. What was the second question? Oh, second. What was the second part? No, actually, because Heineken built two new breweries in Mexico and one in Brazil. Yeah. The question is, was this an existing brewery, somewhere maybe in the Netherlands, or was this for the breweries for them in Mexico and in Brazil? Thank you, Fernand. We cannot specify which breweries exactly, but it could very well be a combination of what you're mentioning. A greenfield and a replacement. Yes, and the positive news is, for us, we've been working with Heineken towards this for quite a while. You can imagine that these big breweries are very aware of quality and reliability. So, we're very proud that we now actually have systems up and running with our membranes, and it might very well be that we're also [inaudible] new developments. So, not specifically those countries, but we do greenfields as well as replacements. Okay, thanks. That was our last question. I would like to now turn the call back over to the host for any closing remarks. Thank you, Lynn. Thank you for the great interaction. Again, we are proud on the progress that we are making. We see very positive underlying metrics. We keep very much a sharp focus on customer outreach and disciplined conversion of orders, and on the flip side, disciplined cost and asset-based management. Thank you for the good interaction, and we are proud to continue on this path, and we work hard every day on it, and we will talk to you hopefully in a half year. That concludes today's presentation. Thank you for joining us. You may now disconnect your line. Please have a great day.